VYNE Therapeutics Inc.
VYNECIK 0001566044 · Every Form 4 filed by insiders at this issuer.
Filings
10
Latest Jan 3, 2024
Unique insiders
10
Showing
10 of 10
Page 1
Top insiders
Most active reporters at VYNE Therapeutics Inc.
| Name | Roles | Filings |
|---|---|---|
| BARBARI SHARON | Director | 1 |
| Basta Steven L | Director | 1 |
| Borowski Christine | Director | 1 |
| Bruno Anthony D | Director | 1 |
| Domzalski David | OfficerDirector | 1 |
| Harsch Mutya | Officer | 1 |
| LEPORE PATRICK G | Director | 1 |
| Sandoval Elisabeth | Director | 1 |
| Stuart Iain | Officer | 1 |
| Zeronda Tyler | Officer | 1 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Jan 3, 2024 | Borowski Christine Director | Holdings only | — | — | — | |
| Jan 3, 2024 | BARBARI SHARON Director | Holdings only | — | — | — | |
| Jan 3, 2024 | Basta Steven L Director | Holdings only | — | — | — | |
| Jan 3, 2024 | Bruno Anthony D Director | Holdings only | — | — | — | |
| Jan 3, 2024 | LEPORE PATRICK G Director | Holdings only | — | — | — | |
| Jan 3, 2024 | Sandoval Elisabeth Director | Holdings only | — | — | — | |
| Jan 3, 2024 | Domzalski David President and CEO · Director | F | 1,004 | $2.28 | $2,289 | |
| Jan 3, 2024 | Harsch Mutya Chief Legal Officer and GC | F | 161 | $2.28 | $367 | |
| Jan 3, 2024 | Stuart Iain Chief Scientific Officer | F | 157 | $2.28 | $358 | |
| Jan 3, 2024 | Zeronda Tyler Chief Financial Officer | F | 93 | $2.28 | $212 |
Showing 1–10 of 10
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.